Correlation Between Samsung Biologics and Iljin HySolus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Samsung Biologics and Iljin HySolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Biologics and Iljin HySolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Samsung Biologics Co and Iljin HySolus Co, you can compare the effects of market volatilities on Samsung Biologics and Iljin HySolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Biologics with a short position of Iljin HySolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Biologics and Iljin HySolus.

Diversification Opportunities for Samsung Biologics and Iljin HySolus

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Samsung and Iljin is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Biologics Co and Iljin HySolus Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iljin HySolus and Samsung Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Biologics Co are associated (or correlated) with Iljin HySolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iljin HySolus has no effect on the direction of Samsung Biologics i.e., Samsung Biologics and Iljin HySolus go up and down completely randomly.

Pair Corralation between Samsung Biologics and Iljin HySolus

Assuming the 90 days trading horizon Samsung Biologics Co is expected to generate 0.58 times more return on investment than Iljin HySolus. However, Samsung Biologics Co is 1.71 times less risky than Iljin HySolus. It trades about -0.05 of its potential returns per unit of risk. Iljin HySolus Co is currently generating about -0.09 per unit of risk. If you would invest  100,000,000  in Samsung Biologics Co on September 1, 2024 and sell it today you would lose (2,500,000) from holding Samsung Biologics Co or give up 2.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

Samsung Biologics Co  vs.  Iljin HySolus Co

 Performance 
       Timeline  
Samsung Biologics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Samsung Biologics Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Samsung Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Iljin HySolus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iljin HySolus Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Iljin HySolus is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Samsung Biologics and Iljin HySolus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Samsung Biologics and Iljin HySolus

The main advantage of trading using opposite Samsung Biologics and Iljin HySolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Biologics position performs unexpectedly, Iljin HySolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iljin HySolus will offset losses from the drop in Iljin HySolus' long position.
The idea behind Samsung Biologics Co and Iljin HySolus Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon